Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 31

1.

High correlation of temporal muscle thickness with lumbar skeletal muscle cross-sectional area in patients with brain metastases.

Leitner J, Pelster S, Schöpf V, Berghoff AS, Woitek R, Asenbaum U, Nenning KH, Widhalm G, Kiesel B, Gatterbauer B, Dieckmann K, Birner P, Prayer D, Preusser M, Furtner J.

PLoS One. 2018 Nov 29;13(11):e0207849. doi: 10.1371/journal.pone.0207849. eCollection 2018.

2.

Brain metastases as first manifestation of advanced cancer: exploratory analysis of 459 patients at a tertiary care center.

Füreder LM, Widhalm G, Gatterbauer B, Dieckmann K, Hainfellner JA, Bartsch R, Zielinski CC, Preusser M, Berghoff AS.

Clin Exp Metastasis. 2018 Dec;35(8):727-738. doi: 10.1007/s10585-018-9947-1. Epub 2018 Nov 12.

3.

Temporal muscle thickness is an independent prognostic marker in melanoma patients with newly diagnosed brain metastases.

Furtner J, Berghoff AS, Schöpf V, Reumann R, Pascher B, Woitek R, Asenbaum U, Pelster S, Leitner J, Widhalm G, Gatterbauer B, Dieckmann K, Höller C, Prayer D, Preusser M.

J Neurooncol. 2018 Oct;140(1):173-178. doi: 10.1007/s11060-018-2948-8. Epub 2018 Jul 14.

4.

Long-term outcome after Gamma Knife radiosurgery for acoustic neuroma of all Koos grades: a single-center study.

Frischer JM, Gruber E, Schöffmann V, Ertl A, Höftberger R, Mallouhi A, Wolfsberger S, Arnoldner C, Eisner W, Knosp E, Kitz K, Gatterbauer B.

J Neurosurg. 2018 Mar 2:1-10. doi: 10.3171/2017.8.JNS171281. [Epub ahead of print]

PMID:
29498575
5.

Multimodality Management of Vein of Galen Malformations-An Institutional Experience.

Hosmann A, El-Garci A, Gatterbauer B, Bavinzski G, Knosp E, Gruber A.

World Neurosurg. 2018 Apr;112:e837-e847. doi: 10.1016/j.wneu.2018.01.172. Epub 2018 Feb 3.

PMID:
29408495
6.

Decreased body mass index is associated with impaired survival in lung cancer patients with brain metastases: A retrospective analysis of 624 patients.

Masel EK, Berghoff AS, Füreder LM, Heicappell P, Schlieter F, Widhalm G, Gatterbauer B, Dieckmann U, Birner P, Bartsch R, Schur S, Watzke HH, Zielinski CC, Preusser M.

Eur J Cancer Care (Engl). 2017 Nov;26(6). doi: 10.1111/ecc.12707. Epub 2017 May 10.

PMID:
28488812
7.

Multimodal treatment of parasagittal meningiomas: a single-center experience.

Gatterbauer B, Gevsek S, Höftberger R, Lütgendorf-Caucig C, Ertl A, Mallouhi A, Kitz K, Knosp E, Frischer JM.

J Neurosurg. 2017 Dec;127(6):1249-1256. doi: 10.3171/2016.9.JNS161859. Epub 2017 Feb 3.

PMID:
28156245
8.

Combining standard clinical blood values for improving survival prediction in patients with newly diagnosed brain metastases-development and validation of the LabBM score.

Berghoff AS, Wolpert F, Holland-Letz T, Koller R, Widhalm G, Gatterbauer B, Dieckmann K, Birner P, Bartsch R, Zielinski CC, Weller M, Preusser M.

Neuro Oncol. 2017 Sep 1;19(9):1255-1262. doi: 10.1093/neuonc/now290.

9.

Survival prediction using temporal muscle thickness measurements on cranial magnetic resonance images in patients with newly diagnosed brain metastases.

Furtner J, Berghoff AS, Albtoush OM, Woitek R, Asenbaum U, Prayer D, Widhalm G, Gatterbauer B, Dieckmann K, Birner P, Aretin B, Bartsch R, Zielinski CC, Schöpf V, Preusser M.

Eur Radiol. 2017 Aug;27(8):3167-3173. doi: 10.1007/s00330-016-4707-6. Epub 2017 Jan 3.

10.

Descriptive statistical analysis of a real life cohort of 2419 patients with brain metastases of solid cancers.

Berghoff AS, Schur S, Füreder LM, Gatterbauer B, Dieckmann K, Widhalm G, Hainfellner J, Zielinski CC, Birner P, Bartsch R, Preusser M.

ESMO Open. 2016 Mar 16;1(2):e000024. eCollection 2016.

11.

Gamma Knife Radiosurgery in Recurrent Glioblastoma.

Frischer JM, Marosi C, Woehrer A, Hainfellner JA, Dieckmann KU, Eiter H, Wang WT, Mallouhi A, Ertl A, Knosp E, Filipits M, Kitz K, Gatterbauer B.

Stereotact Funct Neurosurg. 2016;94(4):265-272. Epub 2016 Oct 8.

PMID:
27721311
12.

Evaluation of Dose-Staged Gamma Knife Radiosurgical Treatment Method for High-Risk Brain Metastases.

Frischer JM, Fraller A, Mallouhi A, Vogl UM, Baier F, Ertl A, Preusser M, Knosp E, Kitz K, Gatterbauer B.

World Neurosurg. 2016 Oct;94:352-359. doi: 10.1016/j.wneu.2016.07.038. Epub 2016 Jul 19.

PMID:
27443227
13.

Alleviation of brain edema and restoration of functional independence by bevacizumab in brain-metastatic breast cancer: a case report.

Berghoff AS, Sax C, Klein M, Furtner J, Dieckmann K, Gatterbauer B, Widhalm G, Rudas M, Zielinski CC, Bartsch R, Preusser M.

Breast Care (Basel). 2014 May;9(2):134-6. doi: 10.1159/000360930.

14.

Microsurgery and radiosurgery for brainstem cavernomas: effective and complementary treatment options.

Frischer JM, Gatterbauer B, Holzer S, Stavrou I, Gruber A, Novak K, Wang WT, Reinprecht A, Mert A, Trattnig S, Mallouhi A, Kitz K, Knosp E.

World Neurosurg. 2014 Mar-Apr;81(3-4):520-8. doi: 10.1016/j.wneu.2014.01.004. Epub 2014 Jan 16.

PMID:
24440458
15.

Relative survival of patients with non-malignant central nervous system tumours: a descriptive study by the Austrian Brain Tumour Registry.

Woehrer A, Hackl M, Waldhör T, Weis S, Pichler J, Olschowski A, Buchroithner J, Maier H, Stockhammer G, Thomé C, Haybaeck J, Payer F, von Campe G, Kiefer A, Würtz F, Vince GH, Sedivy R, Oberndorfer S, Marhold F, Bordihn K, Stiglbauer W, Gruber-Mösenbacher U, Bauer R, Feichtinger J, Reiner-Concin A, Grisold W, Marosi C, Preusser M, Dieckmann K, Slavc I, Gatterbauer B, Widhalm G, Haberler C, Hainfellner JA; Austrian Brain Tumour Registry.

Br J Cancer. 2014 Jan 21;110(2):286-96. doi: 10.1038/bjc.2013.714. Epub 2013 Nov 19.

16.

Susceptibility-weighted imaging at 7 T: Improved diagnosis of cerebral cavernous malformations and associated developmental venous anomalies.

Frischer JM, Göd S, Gruber A, Saringer W, Grabner G, Gatterbauer B, Kitz K, Holzer S, Kronnerwetter C, Hainfellner JA, Knosp E, Trattnig S.

Neuroimage Clin. 2012 Sep 14;1(1):116-20. doi: 10.1016/j.nicl.2012.09.005. eCollection 2012.

17.

Primary central nervous system lymphoma: a clinicopathological study of 75 cases.

Preusser M, Woehrer A, Koperek O, Rottenfusser A, Dieckmann K, Gatterbauer B, Roessler K, Slavc I, Jaeger U, Streubel B, Hainfellner JA, Chott A.

Pathology. 2010;42(6):547-52. doi: 10.3109/00313025.2010.508786.

PMID:
20854073
18.

Surgical target selection in cerebral glioma surgery: linking methionine (MET) PET image fusion and neuronavigation.

Roessler K, Gatterbauer B, Becherer A, Paul M, Kletter K, Prayer D, Hoeftberger R, Hainfellner J, Asenbaum S, Knosp E.

Minim Invasive Neurosurg. 2007 Oct;50(5):273-80.

PMID:
18058643
19.

Proton magnetic resonance spectroscopic imaging in brain tumor diagnosis.

Gruber S, Stadlbauer A, Mlynarik V, Gatterbauer B, Roessler K, Moser E.

Neurosurg Clin N Am. 2005 Jan;16(1):101-14, vi. Review.

PMID:
15561531
20.

Expression of hypoxia-related tissue factors correlates with diminished survival of adjuvantly treated patients with chromosome 1p aberrant oligodendroglial neoplasms and therapeutic implications.

Birner P, Preusser M, Gelpi E, Berger J, Gatterbauer B, Ambros IM, Ambros PF, Acker T, Plate KH, Harris AL, Hainfellner JA.

Clin Cancer Res. 2004 Oct 1;10(19):6567-71.

21.

Fluorescent in situ hybridization on isolated tumor cell nuclei: a sensitive method for 1p and 19q deletion analysis in paraffin-embedded oligodendroglial tumor specimens.

Gelpi E, Ambros IM, Birner P, Luegmayr A, Drlicek M, Fischer I, Kleinert R, Maier H, Huemer M, Gatterbauer B, Anton J, Rössler K, Budka H, Ambros PF, Hainfellner JA.

Mod Pathol. 2003 Jul;16(7):708-15.

22.

Vascular patterns in glioblastoma influence clinical outcome and associate with variable expression of angiogenic proteins: evidence for distinct angiogenic subtypes.

Birner P, Piribauer M, Fischer I, Gatterbauer B, Marosi C, Ambros PF, Ambros IM, Bredel M, Oberhuber G, Rössler K, Budka H, Harris AL, Hainfellner JA.

Brain Pathol. 2003 Apr;13(2):133-43.

PMID:
12744467
23.

Expression of DNA topoisomerase IIalpha in oligodendroglioma.

Bredel M, Gatterbauer B, Birner P, Haberler C, Ströbel T, Budka H, Rössler K, Hainfellner JA.

Anticancer Res. 2002 Mar-Apr;22(2B):1301-4.

PMID:
12168941
24.

High expression of DNA topoisomerase IIalpha and Ki-67 antigen is associated with prolonged survival in glioblastoma patients.

Bredel M, Piribauer M, Marosi C, Birner P, Gatterbauer B, Fischer I, Ströbel T, Rössler K, Budka H, Hainfellner JA.

Eur J Cancer. 2002 Jul;38(10):1343-7.

PMID:
12091064
25.

Prognostic relevance of p53 protein expression in glioblastoma.

Birner P, Piribauer M, Fischer I, Gatterbauer B, Marosi C, Ungersböck K, Rössler K, Budka H, Hainfellner JA.

Oncol Rep. 2002 Jul-Aug;9(4):703-7.

PMID:
12066196
26.

Topoisomerase II alpha as a reliable proliferation marker in meningiomas.

Roessler K, Gatterbauer B, Kitz K.

Neurol Res. 2002 Apr;24(3):241-3.

PMID:
11958416
27.

Expression of hypoxia-inducible factor-1 alpha in oligodendrogliomas: its impact on prognosis and on neoangiogenesis.

Birner P, Gatterbauer B, Oberhuber G, Schindl M, Rössler K, Prodinger A, Budka H, Hainfellner JA.

Cancer. 2001 Jul 1;92(1):165-71.

PMID:
11443623
28.
29.

Antiglycosphingolipid immune responses in neurology. The Vienna experience with isotypes, subclasses, and disease.

Gatterbauer B, Neisser A, Bernheimer H, Schwerer B.

Ann N Y Acad Sci. 1998 Jun 19;845:353-62.

PMID:
9668368
30.

[Cerebrospinal fluid diagnosis of Creutzfeldt-Jakob disease].

Bernheimer H, Gatterbauer B, Radbauer C, Budka H.

Wien Med Wochenschr. 1998;148(4):96-100. German.

PMID:
9611349
31.

Serum antibodies to gangliosides in systemic lupus erythematosus.

Neisser A, Gatterbauer B, Graninger W, Menschik M, Bernheimer H.

Ann N Y Acad Sci. 1997 Aug 14;823:300-2. No abstract available.

PMID:
9292057

Supplemental Content

Loading ...
Support Center